Technology
Results: 15241-15252 of 26832

Ichnos Glenmark Innovation (IGI) Presents First Clinical Data from Phase 1 Study of Trispecific TREAT™ Antibody, ISB 2001, Showing High Overall Response Rate (ORR) with Durable Responses and Favorable Safety Profile in Patients with Heavily Pretreated Multiple Myeloma

Registrar Corp Acquires Personal Care Regulatory (PCR), Expanding Global Cosmetic Regulatory Compliance Services









